Aqualung Therapeutics: Funding, Investors & Team (Sep 2026)
Aqualung Therapeutics (Aqualung Therapeutics Corporation) leadership are experienced academic leaders, entrepreneurs and translational scientists with expertise in Precision Medicine, who are exploring NAMPT as a key target and novel diagnostic in acute and chronic lung inflammatory disorders. As an organization they are committed to finding novel targets in the treatment of respiratory diseases. Their team is highly skilled at clinical development and they are working collaboratively with the FDA to ensure both acute and chronic respiratory diseases that have significant unmet medical need receive priority review.
Aqualung Therapeutics has raised $300k across 1 funding round on record, the most recent an undisclosed round of $300k announced in Sep 2020.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Aqualung Therapeutics Company Profile and Key Stats
Latest funding round on record: Sep 2020.
Aqualung Therapeutics Funding Rounds
Aqualung Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
Aqualung Therapeutics Funding Compared to Other Biotechnology Startups
Aqualung Therapeutics' latest round of $300k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Aqualung Therapeutics in Biotechnology and Tucson
Companies Similar to Aqualung Therapeutics
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Aqualung Therapeutics Funding FAQs
What does Aqualung Therapeutics do?
Aqualung Therapeutics (Aqualung Therapeutics Corporation) leadership are experienced academic leaders, entrepreneurs and translational scientists with expertise in Precision Medicine, who are exploring NAMPT as a key target and novel diagnostic in acute and chronic lung inflammatory disorders. As an organization they are committed to finding novel targets in the treatment of respiratory diseases. Their team is highly skilled at clinical development and they are working collaboratively with the FDA to ensure both acute and chronic respiratory diseases that have significant unmet medical need receive priority review.
How much funding has Aqualung Therapeutics raised?
Aqualung Therapeutics has raised $300k across 1 round on record. The most recent is an undisclosed round of $300k announced in Sep 2020.
When did Aqualung Therapeutics last raise funding?
Aqualung Therapeutics' most recent funding round on record is an undisclosed round of $300k, announced in Sep 2020.
Who is the CEO of Aqualung Therapeutics?
Joe Garcia is listed as CEO at Aqualung Therapeutics.
Where is Aqualung Therapeutics headquartered?
Aqualung Therapeutics is based in Tucson, Arizona, United States.
How many employees does Aqualung Therapeutics have?
Aqualung Therapeutics is in the 1-10 employee band.
How does Aqualung Therapeutics' funding compare to other Biotechnology startups?
Aqualung Therapeutics' latest round of $300k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Aqualung Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Aqualung Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.